Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,293 total articles
Rubrik, Inc. (NYSE: RBRK) director Yvonne Wassenaar sold 721 shares of the company's Class A Common Stock on July 1, 2026, under a Rule 10b5-1 trading plan adopted on December 15, 2025. The transaction, valued at $58,811, was executed at $81.57 per share, closely aligning with the stock's current market price of $82.01. Following the sale, Wassenaa…
Rubrik Inc. (NASDAQ:RBRK) director John Wendell Thompson has completed the sale of 13,500 shares of the company's Class A Common Stock, generating approximately $1.12 million in proceeds. The transactions, executed under a Rule 10b5-1 trading plan established in October 2025, involved both direct sales by Thompson and indirect disposals through a t…
Nayaab Islam, President and Chief Product Officer at StubHub Holdings, Inc. (STUB), executed two separate sales of Class A Common Stock totaling $347,785 on June 29 and June 30, 2026. The transactions were conducted under a pre-established Rule 10b5-1 trading plan adopted in March 2026. This executive activity coincides with a period of significant…
Frank Slootman, a director at Snowflake Inc., sold 99,900 shares of common stock worth approximately $25.1 million on June 29, 2026. The sales were conducted under a pre-arranged 10b5-1 trading plan established in September 2025. On the same date, Slootman acquired an equivalent number of shares by exercising fully vested stock options at an exerci…
Mark Streams, Executive Vice Chairman and Chief Legal Officer at StubHub Holdings, Inc. (NASDAQ: STUB), executed a series of stock sales totaling $240,650 in late June 2026. The transactions involved the disposal of 18,467 shares of Class A Common Stock, conducted under a Rule 10b5-1 trading plan established in December 2025. These sales occurred a…
Axsome Therapeutics, Inc. (NASDAQ:AXSM) CEO Herriot Tabuteau has executed a significant divestment of company shares, selling approximately $11.9 million worth of stock on July 1, 2026. The transaction was facilitated through the exercise of stock options and executed under a pre-established 10b5-1 trading plan. This sale occurs against a backdrop …
Susan M. Byrne, serving as Director Emerita at Westwood Holdings Group Inc. (NASDAQ: WHG), completed a series of stock sales totaling $247,812 between June 26 and June 30, 2026. The transactions were processed through a Rule 10b5-1 trading plan established on April 1, 2026. These sales occurred while WHG shares were trading at $19.22, hovering clos…
Adam Bradley, Melinda Bradley, and affiliated entities recently executed open market purchases of Jewett Cameron Trading Co Ltd (NASDAQ: JCTC) stock, accumulating a total of $42,289 worth of shares between June 26 and June 30, 2026. The transactions, which included direct purchases and acquisitions through the AJB Investment Fund II, LP, bring the …
Todd M. DuChene, serving as the Chief Legal and Administrative Officer at Core Scientific, Inc. (NASDAQ:CORZ), recently completed multiple transactions involving the company's equity. These sales, executed under a pre-existing Rule 10b5-1 trading plan, totaled significant value and occurred amidst a period of notable stock price volatility. The tra…
HRT Financial LP has expanded its stake in Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) through recent acquisitions, buying $110,694 worth of common stock. The investment firm's purchases occurred as the stock traded near its 52-week low of $2.90, following a 92% decline over the past year. Concurrently, Shuttle Pharmaceuticals completed i…
Tim Watkins, Chief Medical Officer and Head of Development at Contineum Therapeutics, Inc. (NASDAQ:CTNM), executed a series of stock transactions on June 30, 2026, involving the exercise of stock options and the subsequent sale of shares. The transactions were conducted under a pre-arranged 10b5-1 trading plan adopted in September 2025. The sale of…
MediaAlpha director Eugene Nonko sold 34,491 shares of the company's Class A Common Stock between June 29 and July 1, 2026, generating approximately $427,815 in proceeds. The sales, conducted through both direct transactions and O.N.E. Holdings, LLC, were executed under a Rule 10b5-1 trading plan established to cover tax obligations from Restricted…
McBee Brannin, CoreWeave's Chief Development Officer, executed a series of Class A Common Stock sales totaling approximately $5.47 million in late June 2026. The transactions, conducted under a Rule 10b5-1 trading plan and to satisfy tax withholding requirements from restricted stock unit vesting, occur as the company's stock price has retreated fr…
Susan Byrne, director emerita at Westwood Holdings Group Inc. (NASDAQ: WHG), has executed a series of stock sales totaling $53,882 across multiple transactions between June 17 and June 22, 2026. The sales were conducted under a Rule 10b5-1 trading plan established on April 1, 2026. The transactions occurred as WHG's stock price ranged from approxim…
John R. Gallagher, Chief Operating Officer at Trupanion, Inc., executed a sale of 431 shares of company common stock on June 29, 2026, totaling $10,925. The transaction was conducted under a Rule 10b5-1 trading plan established in August 2025, removing discretion over the timing of the sale. Gallagher now holds 32,634 shares directly. The sale occu…
Carmine N. Stengone, Chief Executive Officer and President of Contineum Therapeutics, Inc. (NASDAQ: CTNM), has executed a series of stock transactions involving both sales and acquisitions. These activities, conducted under a pre-arranged 10b5-1 trading plan, include the sale of 10,000 shares at a weighted average price of $16.008 and the acquisiti…
MediaAlpha CEO Steven Yi sold 96,000 shares worth approximately $1.24 million on July 1, 2026, under a Rule 10b5-1 plan primarily to cover tax obligations from restricted stock unit vesting. The sale coincides with a 19% weekly stock surge, strong Q1 2026 revenue exceeding forecasts, and the appointment of new board member Lauren StClair.
Steven S. Fendley, President of the US Division at Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), completed a stock sale on June 29, 2026, under a pre-arranged 10b5-1 trading plan. The transaction involved the disposal of 7,000 shares, generating proceeds of $338,556. This disclosure, filed with the Securities and Exchange Commission on …
McBee Brannin, CoreWeave's Chief Development Officer, has executed a series of transactions resulting in the sale of 55,400 Class A Common Stock shares, valued at approximately $5.23 million. The sales, conducted through various trusts including the Canis Major 2024 Irrevocable Trust LLC and several Grantor Retained Annuity Trusts, were facilitated…
CoreWeave, Inc. (CRWV) Chief Development Officer Brannin McBee sold 194,000 shares of Class A Common Stock on June 29, 2026, realizing approximately $18.3 million. The transaction, facilitated by a Rule 10b5-1 trading plan established in March 2026, occurred at prices between $90.24 and $98.31 per share. This activity follows a recent 15% decline i…
Louis Edward Tamayo, Chief Financial Officer of Lexeo Therapeutics, Inc. (NASDAQ:LXEO), executed a sale of 4,641 shares on July 1, 2026, generating $20,838 in proceeds. The transaction, intended to satisfy tax liabilities from performance-based Restricted Stock Units, occurred at an average price of $4.49 per share. This activity follows the compan…
C3.ai Inc. (NASDAQ: AI) reported that Chief Financial Officer Hitesh Lath sold $426,388 worth of Class A Common Stock on June 30, 2026, according to a recent SEC filing. The transaction involved 48,619 shares at a weighted-average price of $8.77, with the stock currently trading at $9.43. While the company issued preliminary fiscal 2027 revenue gui…
Sunrun Inc. director Lynn Michelle Jurich recently liquidated a portion of her equity stake, selling 50,000 shares for $680,320. The transaction, executed on July 1, 2026, follows a Rule 10b5-1 trading plan adopted in June 2025. This insider activity unfolds against a backdrop of recent financial outperformance and shifting analyst projections for …
Richard Nolan Townsend, Chief Executive Officer of Lexeo Therapeutics, Inc. (NASDAQ:LXEO), executed a sale of 25,947 shares of common stock on July 1, 2026, totaling $116,242. The transaction, conducted at prices ranging from $4.3402 to $4.7507 with a weighted average of $4.48 per share, was specifically designated to satisfy tax liabilities arisin…
Neil Harris Blumenthal, Co-Chief Executive Officer of Warby Parker Inc., executed a sale of 36,300 shares of Class A Common Stock on June 29, 2026, resulting in proceeds totaling approximately $1,090,452. The transaction, governed by a Rule 10b5-1 trading plan adopted on September 16, 2025, occurred at per-share prices between $29.99 and $30.35. Th…
